Skip to main content
ORMP logo
ORMP
(NASDAQ)
Oramed Pharmaceuticals Inc.
$4.98-- (--)
Loading... - Market loading

Oramed Pharmaceuticals (ORMP) Stock Price & Financial Analysis

Oramed Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.92 - $5.01
52-Week High$5.47
52-Week Low$2.09
Open$4.99
Volume117.88K
Average Volume (3M)211.23K
Market Cap210.27M
Shares Outstanding41.97M
P/E Ratio (TTM)1.56
Price to Book (P/B)0.88
EV/EBITDA3.18
50-Day MA$4.47
200-Day MA$3.75
52-Week Change116.52%
Annual Dividend$0.25
Dividend Yield5.02%
Payout Ratio7.83%
Last Dividend Ex-DateJan 16, 2026

Frequently Asked Questions About Oramed Pharmaceuticals

What is the current stock price for ORMP?

As of the latest trading session, ORMP stock trades at $4.98. The 52-week range is $2.09–$5.47, with a day range of $4.92–$5.01.

What is the P/E ratio for ORMP?

Oramed Pharmaceuticals's trailing P/E ratio is 1.6, meaning investors pay $1.6 for every $1 of annual earnings. Oramed Pharmaceuticals operates in the Healthcare sector.

Does ORMP pay dividends?

Yes, Oramed Pharmaceuticals pays a 5.02% annual dividend yield ($0.25 per share). The payout ratio is 7.8%. The last ex-dividend date was 2026-01-16.

What do analysts recommend for ORMP?

Analyst ratings and recommendations for ORMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ORMP?

Oramed Pharmaceuticals's market capitalization is $209.0M, classifying it as a micro-cap company. Oramed Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.